198.10SEK+0.28%Mkt Cap: 5.16B $P/E: 22.881d ago
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, a…
Indicators:|
Key Statistics
Company
Market Cap5.16B $
Enterprise Value5.82B $
Revenue (TTM)3.26B $
Gross Profit1.59B $
Net Income (TTM)215.98M $
Revenue/Share11.97 USD
Last Price198.10 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees11.8K
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINUS37427X1046
Valuation
P/E (Trailing)22.88
P/E (Forward)18.19
PEG1.56
EV/EBITDA11.14
EV/Revenue1.78
P/S1.59
P/B1.75
EPS (TTM)8.65
EPS (Forward)10.94
52W Range
175.9040% of range231.60
52W High231.60 SEK
52W Low175.90 SEK
Profitability
Gross Margin47.63%
Oper. Margin9.92%
EBITDA Margin16.02%
Profit Margin6.46%
ROE7.67%
ROA4.00%
Growth
Revenue Growth-10.50%
Earnings Growth33.70%
Cash Flow & Leverage
Operating CF377.73M $
CapEx (TTM)125.69M $
FCF Margin8.58%
FCF Yield5.42%
Net Debt666.50M $
Net Debt/EBITDA1.28
Balance Sheet
Debt/Equity0.37
Current Ratio1.35
Quick Ratio0.84
Book Value/Sh113.72 SEK
Cash/Share14.76 SEK
Dividends
Fwd Div Rate4.750 SEK
Trail. Div Rate4.750 SEK
Div. Yield2.40%
5Y Avg Yield1.87%
Payout Ratio53.12%
Ex-Div DateApr 22, 2026
Pay Date—
Splits
Last Split4:1
Split DateNov 27, 2003
Analyst Consensus
Rating2.2 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)227.20 SEK
Upside (mean)+14.7%
Target Range165.00 SEK – 270.00 SEK
SEK165.00+14.7% to meanSEK270.00
# Analysts10
Ownership
Shares Out.254.15M
Float178.53M
Insiders15.76%
Institutions64.46%
Technical
SMA 50192.24 (+3.0%)
SMA 200203.21 (-2.5%)
Beta0.79
S&P 52W Chg18.52%
Avg Vol (30d)482.41K
Avg Vol (10d)450.65K
Technical Indicators
RSI (14)58.0
MACD1.5111
MACD Signal0.9202
MACD Hist.+0.5909
BB Upper201.04 SEK
BB Middle193.22 SEK
BB Lower185.39 SEK
BB Width8.10%
ATR (14)4.052 SEK
Vol Ratio (20d)1.15x